Gubbins PO - Search Results

1

Clinically relevant drug interactions of current antifungal agents.

Gubbins PO, Heldenbrand S. Gubbins PO, et al. Mycoses. 2010 Mar 1;53(2):95-113. doi: 10.1111/j.1439-0507.2009.01820.x. Epub 2009 Dec 11. Mycoses. 2010. PMID: 20002883 Review.

2

Smartphone medication adherence apps: potential benefits to patients and providers.

Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Dayer L, et al. Among authors: gubbins po. J Am Pharm Assoc (2003). 2013 Mar-Apr;53(2):172-81. doi: 10.1331/JAPhA.2013.12202. J Am Pharm Assoc (2003). 2013. PMID: 23571625 Free PMC article.

3

Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum.

Heldenbrand SD, Flowers SK, Bordelon BJ, Gubbins PO, O'Brien C, Stowe CD, Martin BC. Heldenbrand SD, et al. Among authors: gubbins po. Am J Pharm Educ. 2016 Mar 25;80(2):27. doi: 10.5688/ajpe80227. Am J Pharm Educ. 2016. PMID: 27073280 Free PMC article.

4

Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points.

Dayer LE, Shilling R, Van Valkenburg M, Martin BC, Gubbins PO, Hadden K, Heldenbrand S. Dayer LE, et al. Among authors: gubbins po. JMIR Mhealth Uhealth. 2017 Apr 19;5(4):e45. doi: 10.2196/mhealth.6582. JMIR Mhealth Uhealth. 2017. PMID: 28428169 Free PMC article.

5

APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA.

Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK. Heldenbrand SD, et al. Among authors: gubbins po. Am J Pharm Educ. 2018 Sep;82(7):6326. doi: 10.5688/ajpe6326. Am J Pharm Educ. 2018. PMID: 30323388 Free PMC article.

6

Drug-drug interactions of antifungal agents and implications for patient care.

Gubbins PO, Amsden JR. Gubbins PO, et al. Expert Opin Pharmacother. 2005 Oct;6(13):2231-43. doi: 10.1517/14656566.6.13.2231. Expert Opin Pharmacother. 2005. PMID: 16218884 Review.

7

Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.

Gubbins PO. Gubbins PO. Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1411-29. doi: 10.1517/17425255.2011.627854. Epub 2011 Oct 13. Expert Opin Drug Metab Toxicol. 2011. PMID: 21995615 Review.

8

Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients.

Gubbins PO. Gubbins PO. Curr Opin Infect Dis. 2007 Dec;20(6):579-86. doi: 10.1097/QCO.0b013e3282f1be91. Curr Opin Infect Dis. 2007. PMID: 17975407 Review.

9

Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst.

Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Dayer L, et al. Among authors: gubbins po. J Am Pharm Assoc (2003). 2013 Jul-Aug;53(4):345. doi: 10.1331/JAPhA.2013.13121. J Am Pharm Assoc (2003). 2013. PMID: 23892801 No abstract available.

10

Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients.

Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L. Heldenbrand S, et al. Among authors: gubbins po. J Am Pharm Assoc (2003). 2016 May-Jun;56(3):293-302. doi: 10.1016/j.japh.2015.12.014. Epub 2016 Apr 7. J Am Pharm Assoc (2003). 2016. PMID: 27067551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page